Lantheus Holdings, Inc.
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound en…
Drug Manufacturers - Specialty & Generic
US, North Billerica [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Lantheus Holdings, Inc.'s gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2015 | - | 0.438 | - | 293 | - | 30 | - | 18 | - | 0.00 | - | 93 |
| 2016 | -0.6000 | 0.658 | 293 | 298 | -14 | 25 | 42 | 68 | 42 | 52 | 78 | 70 |
| 2017 | 0.8400 | 1.093 | 301 | 327 | 26 | 145 | 50 | 72 | 50 | 46 | 75 | 85 |
| 2018 | 3.3100 | 0.850 | 331 | 340 | 123 | 30 | 60 | 61 | 51 | 49 | 92 | 71 |
| 2019 | 1.0600 | 1.127 | 343 | 348 | 40 | 27 | 66 | 48 | 64 | 45 | 93 | 87 |
| 2020 | 0.8100 | 0.454 | 347 | 337 | 31 | -30 | 45 | 51 | 51 | -11 | 103 | 212 |
| 2021 | -0.2500 | 0.413 | 339 | 407 | -13 | 6 | -2 | 127 | -4 | 50 | 110 | 308 |
| 2022 | -1.0600 | 3.836 | 425 | 916 | -71 | 33 | -83 | 97 | -76 | 65 | 218 | 187 |
| 2023 | 0.4100 | 5.920 | 935 | 1,281 | 28 | 428 | 34 | 96 | 36 | 61 | 233 | 204 |
| 2024 | 4.7900 | 6.665 | 1,296 | 1,519 | 326 | 468 | 444 | 93 | 364 | 0.02 | 267 | 483 |
| 2025 | - | 7.201 | - | 1,656 | - | 502 | - | 102 | - | 0.03 | - | 527 |
| 2026 | - | 2.F11X/td> | - | 2.F11X/td> | - | 2.F11X/td> | - | 2.F111/td> | - | 2.F111 | - | 2.F111 |
| 2027 | - | 1.F12X/td> | - | 1.F12X/td> | - | 1.F12X/td> | - | 1.F121/td> | - | 1.F121 | - | 1.F121 |
| 2028 | - | 0.F13X/td> | - | 0.F13X/td> | - | 0.F13X/td> | - | 0.F131/td> | - | 0.F131 | - | 0.F131 |